by Jordana Choucair | Jan 6, 2022 | Life Sciences
According to a Stat News review, major health care systems are not offering Aduhelm, Biogen Inc.’s controversial Alzheimer’s disease drug. The review identified 15 additional academic medical centers that aren’t prescribing it, including seven that...
by Jordana Choucair | Jan 6, 2022 | Life Sciences
A new study raises concerns about whether at-home rapid antigen tests can detect the Omicron variant before infected people can transmit the virus to others. The study looked at 30 people who received both the antigen tests and a PCR daily test, which is believed to...
by Jordana Choucair | Jan 6, 2022 | Life Sciences
The CDC said that it doesn’t have any plans to change the definition of “full vaccination” for COVID-19. According to the agency, people who have had three doses of Pfizer-BioNTech or Moderna Inc.’s vaccines, or those who have had a second dose after...
by Jordana Choucair | Jan 6, 2022 | Life Sciences
The CDC recommended that adolescents ages 12 to 15 get a booster dose of Pfizer Inc.-BioNTech SE’s COVID-19 vaccine, after an advisory panel voted 13-1 in favor of the guidance. The decision, which applies to 10 million young people, comes as the Omicron variant...
by Jordana Choucair | Jan 5, 2022 | Life Sciences
COVID-19 vaccine partners Pfizer and BioNTech SE are working together to develop an mRNA vaccine for shingles. BioNTech is contributing its proprietary mRNA technology while Pfizer is offering its antigen research. The drugmakers hope their shingles shot will be...
by Jordana Choucair | Jan 4, 2022 | Life Sciences
The CMS dropped a Trump-era rule that would have tied Medicare prices for some outpatient drugs to the lowest prices paid by other wealthy countries, citing procedural issues with how it was initially put in place. The rule, known as the most favored national policy,...
Recent Comments